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Abstract
Acetylcholine (ACh) release by starburst amacrine cells (SACs) has been implicated in the production of retinal waves during
early retinal development. Inhibitory gamma-aminobutyric acid (GABA) release by SACs is known to be involved in directional
selectivity in the mature retina. However, the role of SAC release of ACh in the adult developed mammalian retina is not entirely
understood. Some evidence suggests a neuroprotective effect on retinal ganglion cells (RGCs) acting through alpha7 nicotinic
acetylcholine receptors (nAChRs) present in RGCs. If ACh released by SACs is neuroprotective to RGCs, it would follow that
this cholinergic transmission might be compromised in glaucoma conditions, at a time point prior to RGC loss. In this study,
hypertonic saline injections into the episcleral veins surrounding the eyes of adult Long Evans rats were used to induce glaucomalike conditions. The effect of this rat glaucoma model on starburst amacrine cell populations was examined at various time points
post-insult. Additionally, ACh content within the retina and the expression of nAChRs within the retina were analyzed. It was
found that starburst amacrine cell numbers, ACh content, and alpha7 nAChR expression all began to decrease one week after the
procedure to induce glaucoma-like conditions, preceding the significant loss of RGCs that typically occurs one month after the
same procedure. In pharmacological studies, DMP-543 and Donepezil were used to enhance the effect of ACh at the amacrine
cell-RGC synapse. Each of these agents increased RGC survival in the induced glaucoma model. The results obtained from this
study support the hypothesis that SACs mediate cholinergic neuroprotection for RGCs. This indicates a potentially novel role of
ACh released from SACs in the mature mammalian retina.
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Introduction
Glaucoma is a group of degenerative retinal diseases characterized by progressive loss of retinal ganglion
cells (RGCs) and their axons that make up the optic nerve
leading to irreversible loss of vision. As a leading cause
of irreversible blindness in the world, it is estimated that
there will be 79.6 million patients with glaucoma by 2020
[1]. Currently, the cause of glaucoma is not completely
understood and no cure has been identified. The primary risk factor of glaucoma is an increase of intraocular
pressure (IOP) and all current treatments are designed

to lower IOP [2-4]. However, these treatments alone are
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ciated with this disease. Even after successful IOP reduction, RGCs can continue to die [5-7]. Successful future
glaucoma treatments will likely involve a combination of
IOP reduction and neuroprotective treatments.
Neuroprotection has been defined as any intervention
that prevents optic nerve damage or RGC death [8]. However, the development of neuroprotective treatment options provides a challenge because of the wide range of
suspected pathological processes involved in the loss of
RGCs associated with glaucoma. The neurotransmitter,
acetylcholine (ACh), has been linked to neuroprotection
against excitotoxic cell death and neurodegenerative diseases of the central nervous system (CNS) [9-15]. Results
from our lab have demonstrated that acetylcholine provides neuroprotection against glutamate-induced excitotoxicity in isolated pig and rat RGCs in vitro [16-18]. Additional studies using an in vivo rat model of glaucoma
have shown that intravitreal injections or eye drop application of the α7 nAChR selective agonist, PNU-282987,
triggers neuroprotection against the loss of RGCs normally associated with glaucoma through activation of α7
nAChRs [19,20].
A specific population of cells in the retina, the starburst
amacrine cells (SACs), are known to release ACh in the
mammalian retina [21]. Amacrine cells are interneurons of
the retina that make synapses with ganglion cells as well as
bipolar cells in the inner plexiform layer (IPL). There are an
estimated 40 types of amacrine cells in the vertebrate retina
based on morphology, synapses and chemical messengers
they contain [22]. Different types are classified by the width
of their receptive fields, their stratification patterns, and by
the type of neurotransmitter they release. Of these many
types of amacrine cells, SACs are the only type known to
release acetylcholine. There are two known populations of
SACs. ACh-a-type starburst amacrine cell bodies are located in the INL and their dendrites stratify to stratum 2 of the
IPL. The focus of this study was on displaced amacrine cells
(ACh-b type), whose cell bodies lie in the GCL and whose
dendrites stratify in strata 4 of sublamina b in the IPL. Displaced SACs synapse directly onto RGCs [22-25].
During early retinal development, SACs release ACh,
which is necessary for the production of retinal waves
[26,27]. In addition to ACh, SACs also release inhibitory gamma-aminobutyric acid (GABA) in the vertebrate
retina onto nAChRs of directionally selective (DS) RGCs
[26-32]. However, the role of ACh released from SACs in
the developed, mature retina is unclear [27,33].
If ACh is neuroprotective to RGCs in vitro [16,18]
and SACs are known to release ACh onto this receptor
in RGCs of the mammalian retina, do SACs provide endogenous neuroprotection to RGCs in the adult vertebrate retina through the release of ACh? What happens
Cooley-Themm et al. J Ophthalmic Res Ocular Care 2017, 1(1):28-38

to this transmission of ACh from displaced SACs under
glaucoma conditions when RGCs die? Multiple studies
investigating starburst amacrine cell survival using various glaucoma models have reported inconclusive and
opposing results [34-36].
This study analyzes changes that occur in the cholinergic
synapse between SACs and RGCs in glaucomatous conditions induced by hypertonic saline injections to the episcleral vein. Using this well-developed hypertonic glaucoma
model in adult rats [19-20,37] our lab has measured significant RGC loss at one month after surgery that is correlated
with an increase of intraocular pressure [19]. However, the
effects of this glaucoma model on displaced SAC populations have not been analyzed. In this study, it is proposed
that the transmission of ACh from SACs onto RGCs provides endogenous neuroprotection to RGCs in the mammalian retina and that this transmission is compromised
in glaucoma-like conditions. Therefore, it is predicted that
cholinergic SACs are lost in glaucoma-like conditions induced by hypertonic saline injections to the episcleral vein.
This study will also demonstrate that the loss of displaced
SACs correlates with a loss of ACh and loss of RGCs at
a later time point. Lastly, the application of agents to enhance the effect of ACh at the amacrine cell-RGC synapse
will be shown to increase RGC numbers after the induction
of glaucoma. These studies are the first to suggest a novel
neuroprotective role of the cholinergic SACs in the mature
mammalian retina and provide an exciting new frontier in
the fields of glaucoma and neuroprotection.

Materials and Methods
Animals
All experiments were performed on male or female
Long Evans rats 3-6 months of age. The rats were bred
and raised in the animal facility of Western Michigan
University. They were kept at 20-25 degrees Celsius under a 12 hour light/dark cycle with free access to food and
water. The experimental procedures were in accordance
with the IACUC protocol at Western Michigan University.

Hypertonic saline injection to induce glaucomalike conditions
Hypertonic saline injections into the episcleral veins
of rat eyes, have been shown to cause a significant loss
of RGCs and a significant increase of intraocular pressure (IOP) within one month [19,37]. The injection causes blanching of the episcleral veins and scarring of the
trabecular meshwork system to reduce aqueous outflow
[37]. To induce glaucoma-like conditions using this procedure, adult Long Evans rats were anesthetized with an
intraperitoneal injection of KAX cocktail at 0.1 ml/100
gm. KAX is made up of 5 ml of ketamine (100 mg/ml),
ISSN: 2578-7160 |
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2.5 ml xylazine (20 mg/ml), 1 ml acepromazine (10 mg/
ml), and 3 ml sterile water. When loss of withdrawal reflex after toe pinch was confirmed, the whiskers were
trimmed and a topical anesthetic of proparacaine hydrochloride was applied to the eye to prevent reflex activity.
A hemostat was then used to clamp the tissue surrounding the eye to bulge the experimental eye. In each animal,
only one eye was injected with hypertonic saline to induce glaucoma. The other eye was left untreated and acted as an internal control. The episcleral vein of each experimental eye was then injected with 50 µl of 2M NaCl
using a beveled glass microinjection needle [19]. Noticeable blanching of the episcleral vein was used to confirm
successful injection [19]. In some control experiments,
the hemostat was used to bulge the eye in untreated control eyes as well as in eyes that underwent the procedure
to induce glaucoma-like conditions. The clamping of the
hemostat had no aberrant stretching effect on the optic
nerve that affected experimental outcomes. After the procedure, topical antibiotic was applied to experimental eyes
and animals were monitored until full consciousness was
restored. The animals were then returned to the animal
facility until sacrificed at designated time points for immunohistochemical analysis.

Retina removal and preparation
At various time points after the procedure to induce
glaucoma-like conditions, animals were sacrificed by CO2
asphyxiation. Rat eyes were then enucleated and the retinas were removed. Whole retinas were laid flat by cutting four small incisions in the retina to form four quadrants radiating from the optic nerve head (ONH). Retinas were pinned flat with the RGC layer facing up with
cactus needles in sylgard coated petri dishes [19]. Retinas
were then fixed overnight with 4% paraformaldehyde at
room temperature.

Immunohistochemistry
RGCs were labeled with antibodies against the cell specific marker that labels Thy 1.1 glycoprotein in the plasma
membrane [38]. SACs were identified with an antibody
against the enzyme choline acetyltransferase (ChAT) responsible for synthesizing ACh. SACs are the only cells in
the vertebrate retina capable of synthesizing ACh. Therefore, this antibody is commonly used to specifically identify
populations of SACs. In some experiments, apoptotic cells
were labeled with an antibody against cleaved caspase-3.
Briefly, fixed and flat-mounted retinas were permeabilized
and blocked with 1% Triton-X 100 with 1% FBS in PBS for
an hour and 45 minutes at room temperature. Next, fixed
retinas were submerged in 0.1% Triton X-100 in PBS for 5
minutes. Retinas were then rinsed twice in PBS for 5 minutes. Finally, each retina was incubated in mouse primary
antibody anti rat-Thy 1.1 (1:300, 0.5 mg/mL, BD PharminCooley-Themm et al. J Ophthalmic Res Ocular Care 2017, 1(1):28-38

gen 554892), sheep anti rat-ChAT (1:5000, 0.5 mg/mL,
ABCAM Ab18736), or rabbit anti-rat cleaved caspase-3
(Asp175) (1:300, 10 mM, Cell Signaling Technology #9661)
overnight at room temperature. The following day, after
rinsing, retinas were incubated in secondary antibody with
either goat anti-mouse Alexa Fluor 594 (1:300, 2 mg/mL,
Life Technologies, A11005) and donkey anti-sheep Alexa
Fluor 488 (1:300, 2 mg/mL, Life Technologies, A11015) or
donkey anti-rabbit Alexa Fluor 594 (1:300, 2 mg/Ml, Life
Technologies, A21207) overnight at room temperature. The
following day, retinas were liberally washed with PBS and
mounted on microscope slides with 50% glycerol/50% PBS
for viewing.

Confocal microscopy and data analysis
All stained retinas were visualized with a Nikon C2+
scanning laser confocal microscope. Using the z-stack acquisition function of the microscope, a minimum of four
high resolution z-stacks were obtained, 4 mm from the
ONH, from each of the 4 quadrants of each retina [19-20].
Image J software was then used to visualize each z-stack
and allow the counter to scroll beneath axon bundles
found in the nerve cell layer. A fixed 200 × 200 µm2 grid
was applied to all images and the Thy 1.1-positive RGCs
within the grid for each retinal quadrant were counted
blindly. In the same manner, ChAT-positive SACs were
counted. The counts from the 4 quadrants were averaged
for each retina. The average number of Thy 1.1-positive
RGCs and ChAT-positive SACs in a retina represented
an N of 1.

IOP measurements
IOP measurements were obtained daily from awake rats
before and after hypertonic injections into the episcleral
veins using a rebound tonometer (Mentor 0 & 0, Inc) [1920,39]. Briefly, animals were removed from their home cages and held gently. A handheld rebound tonometer was then
applied to experimental eyes to obtain IOP measurements
before and after hypertonic injections were performed. On
each day, 3 IOP measurements were obtained from each
experimental animal and averaged. This was performed for
between 8 and 20 animals depending on designated end
time point specified by experimental protocols.

LC/MS/MS analysis
At the designated time points after glaucoma-inducing
surgery, animals were sacrificed by CO2asphyxiation. Retinas were removed, rinsed in PBS, weighed, and immediately packaged in dry ice for delivery to the Michigan Innovation Center of Kalamazoo, MI for LC/MS/MS analysis
and quantification of ACh. LC/MS/MS was performed on a
Waters Quattro Micro triple quadrupole mass spectrometer using positive ion electrospray ionization. A Waters CapLC capillary HPLC was configured for on-line SPE. Each
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sample was done in triplicate. ACh concentration data was
obtained for each sample from the Michigan Innovation
Center of Kalamazoo after producing a standard curve. The
average for each experimental condition was calculated and
compared to controls to determine if ACh levels decrease
after inducing glaucoma and to determine if this loss correlates to the loss of ChAT-positive cells.

ELISA assay
Following glaucoma inducing surgery, animals were sacrificed at designated time points. All retinas were removed
and extensively homogenized for approximately 3 minutes
using a plastic pestle and homogenization tube (Kimble-Chase #749521-1590) in 500 µL PBS, according to kit
instructions. Then, retinas were centrifuged at 5000 rpm for
15 minutes. The supernatant was collected and serial dilutions were made. Quantification of α7 nAChRs in each
serial dilution was performed using the rat neuronal acetylcholine receptor subunit alpha-7 ELISA kit from MyBioSource (Cat: MBS9340394) according to kit instructions
using a generated standard curve. Measurements of absorbance at 450 nm were obtained with a BioTek Epoch microplate reader. The average absorbance was calculated for
each sample condition and the absorbance of the blank was
subtracted to give the adjusted value. The adjusted absorbance was then used to calculate the average optical density
in terms of concentration in ng/gm of retinal tissue.

Agonist administration
For three days prior to glaucoma induction, rats received once daily eye drops of either DMP-543 (TOCRIS Bioscience, Cat No. 2330) or Donepezil (Sigma-Aldrich, D6821) at various concentrations in the right eye
only. The left eye in each animal acted as an untreated
internal control. The following day, the right eye of each
animal was induced with glaucoma as outlined previously. Each animal then received specified eye drops
once daily for two weeks after glaucoma induction. All
animals were sacrificed at four weeks after the procedure to induce glaucoma. Retinas were removed, fixed
in 4% paraformaldehyde overnight at room temperature,
flat-mounted, and stained with an antibody against Thy
1.1 as described above. Stained retinas were then analyzed
for RGC quantification. Quantification took place in the
same manner previously described for quantification of
ChAT-positive SACs, except that Thy 1.1-positive RGCs
were counted.

mRNA sequencing
Animals were injected with hypertonic saline to induce
glaucoma-like conditions as outlined above and sacrificed 3
days later by CO2 asphyxiation. Upon immediate retinal removal, an RNEasy Plus Mini Kit (Qiagen, Cat No. 74134)
Cooley-Themm et al. J Ophthalmic Res Ocular Care 2017, 1(1):28-38

was used to extract total RNA according to kit instructions.
Total RNA yield was verified using a Thermo Scientific
nano drop 2000 spectrophotometer. Samples were then
sent on dry ice to GENEWIZ, Inc. for differential gene expression analysis using Illumina HiSeq technology as well
as bioinformatics analysis. Gene hit counts and expression
values were calculated, transformed, and normalized. The
fold change was calculated between different samples and
pair-wise comparisons were generated. Pathway enrichment analysis was then performed on selected genes known
to be involved in cell survival pathways and analyzed for up
or down fold changes in expression.

Statistical analysis
Statistical analyses were performed using one way ANOVA in all experiments with Tukey post-hoc analysis. P ≤
0.05 was considered statistically significant for all analyses. Cell counts from experimentally treated retinas were
compared to cell counts obtained from untreated control
retinas. P ≤ 0.05 represented significance from untreated
controls.

Results
Time-dependent effect of glaucoma-inducing surgery on starburst amacrine cell and retinal ganglion
cell survival
To assess the effect of induced glaucoma on SAC numbers, immunohistochemical analysis was performed on
retinal flat mounts 3 days, 1 week, 2 weeks, 3 weeks, or 4
weeks after the procedure to induce glaucoma-like conditions. Retinas were double stained with antibodies against
the RGC marker, Thy 1.1, and the starburst amacrine cell
marker, ChAT and visualized using fluorescent secondary
antibodies. Figure 1 illustrates a confocal image of a double-stained control untreated retina taken 4 mm from the
optic nerve head (ONH). The arrow head points to a labeled
RGC body (red), whereas the double ended arrow lies along
a RGC axon fascicle (red). Displaced starburst amacrine cells
are evenly distributed throughout the GCL and labeled green
(arrow).
In Figure 2, images were obtained using confocal microscopy under control untreated conditions (Figure 2A), one
week (Figure 2B), and four weeks (Figure 2C) after inducing glaucoma with hypertonic saline injections. Four weeks
after the procedure, there was a loss of RGC bodies (arrow
head) (Figure 2C and Figure 3A). Quantification of stained
ChAT-positive cells from the confocal images indicated
that a significant decrease in SAC number occurred as early
as one-week post-insult, as compared to untreated control
retinas from the same animal (Figure 2 and Figure 3). This
significant loss persisted through the later time points and is
summarized in Figure 3. RGC ANOVA (F(5, 90) = 67.2569,
ISSN: 2578-7160 |
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p = 6.7E-29) SAC ANOVA (F(5, 84) = 31.3123, p = 7.4E-18).

IOP measurements
IOP measurements were taken to assess the successful
induction of glaucoma-like conditions in experimental

eyes. The results of the obtained averaged IOP measurements are summarized in Figure 3C. Before inducing
glaucoma-like conditions, the mean IOP measured in adult
awake Long Evans rats equaled 11.5 mm Hg (± 2.5 n = 8).
A steady increase in IOP was measured across the time
points measured. A significant increase from the internal
control eye was measured 21 days after the induction of
glaucoma-like conditions with an average IOP measurement of 17.5 mm Hg (± 3.3 n = 8) and increased to an
average of 22.2 mm Hg (± 2.5 n = 8) 29 days after the hypertonic saline injection procedure. These results show
that hypertonic saline injections used to induce glaucoma-like conditions were successful in increasing IOP in
experimental eyes.

Caspase expression

Figure 1: Immunostained control untreated retina. This figure shows a representative confocal image of a flat-mounted
control untreated retina that was double-stained for RGCs
and SACs. RGCs are shown in red, using an antibody against
the RGC specific marker, Thy 1.1. RGC axons are indicated
with the double arrow. The block arrow identifies a choline
acetyltransferase (ChAT)-positive (green) displaced starburst amacrine cell lying within the retinal ganglion cell layer.
The double arrow indicates an RGC axon bundle. The arrowhead indicates a Thy 1.1-positive (red) RGC. This image
is representative of the total number of images collected for
analysis. The scale bar represents 50 μm.

To provide evidence that the procedure to induce glaucoma in adult rats involves apoptosis of SACs, glaucomatous retinas were double-stained with antibodies against
ChAT and cleaved caspase-3. Figure 4A shows a control
untreated retina where ChAT-positive SACs (green) are
seen (arrow). No evidence of caspase-3 (red) can be found.
Figure 4B shows caspase-3 positive cells 3 days after hypertonic saline injections. Some ChAT-positive SACs are
double labeled with the antibody against caspase-3 (orange; arrowhead). These results support the hypothesis
that SACs begin to undergo apoptotic cell death as early as
3 days after glaucoma-inducing surgery.

Acetylcholine content
To determine if the loss of starburst amacrine cell numbers correlates with a loss of ACh content, LC/MS/MS
analysis was performed on whole retinas. Figure 5 summarizes the average ACh content obtained from adult rat
retinas analyzed at multiple time points before and after

Figure 2: SAC survival in glaucomatous retinas. This figure shows a confocal control untreated retina (A) glaucomatous retina one week after the procedure to induce glaucoma (B), and four weeks post-procedure (C). RGC bodies (arrow head) are
shown in red, using anti-Thy1.1 antibody. Double arrows represent axon fascicles. Displaced SACs are shown in green, using
anti-choline acetyltransferase (ChAT) antibody. These images are representative of the total number of images collected for
analysis. The scale bar represents 50 μm.
Cooley-Themm et al. J Ophthalmic Res Ocular Care 2017, 1(1):28-38
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Figure 3: Quantification of RGCs and SACs in glaucoma-induced retinas. This figure summarizes RGC count data (A) and
SAC count data (B) at various time points post-surgery to induce glaucoma. Cells were immunostained with antibodies against
Thy.1.1 and ChAT. A minimum of four high resolution confocal images were taken per retina, one from each quadrant 4 mm
from the ONH. ChAT-positive cells were counted and averaged for each retina (N = 1). The bar graph represents the mean
SAC count for each experimental condition. *indicates a significant change as compared to the untreated control condition. (C)
represents average IOP measurements obtained before after inducing glaucoma at different time points. P ≤ 0.05 represents
significance. Error bars report the standard error. Ns of 8 are represented.

Figure 4: Caspase expression in glaucomatous retinas. This figure shows SACs in a control untreated retina (A) and SACs in
a retina 3 days after the procedure to induce glaucoma (B). SACs in the flat-mounted retina were double immunostained with
antibodies against both ChAT (green) and caspase-3 (red). These images are representative of the total number of images
collected for analysis. The scale bar represents 50 μm.

the procedure to induce glaucoma. The results demonstrate a significant loss of ACh in the retina as early as
one week post-procedure, as compared to the untreated control condition. ANOVA (F(5, 18) = 43.2863, p =
2.1E-09). In addition, ACh content decreased in a time
dependent manner between 1 and 4 weeks after the procedure to induce glaucoma-like conditions (Figure 5).

Receptor protein expression
In order to examine the changes in α7 nAChR expression after glaucoma induction, ELISA analysis was performed on whole retinas under each experimental condition according to EKISA kit instructions. ELISA analysis
revealed that significant loss of the α7 nAChRs occurred
within one week of the procedure to induce glaucoma
(Figure 6). This significant loss was maintained through
all later time points. ANOVA (F(5, 6) = 5.66642, p =
0.02839).

Agonist treatment
The hypothesis of this study states that ACh released
Cooley-Themm et al. J Ophthalmic Res Ocular Care 2017, 1(1):28-38

Figure 5: LC/MS/MS analysis for ACh content in experimental
retinas. This figure summarizes the average ACh concentration
measured in ng/gm of tissue for untreated control and glaucomatous retinas at different time points post-surgery using LC/
MS/MS technology. *indicates a significant decrease in ACh
concentration compared to the untreated control condition. Error bars report the standard error. P ≤ 0.05 represents significance. Ns of 6 are represented.

from SACs within the adult mammalian retina is neuroprotective to RGCs and that this transmission is lost in
glaucoma-like conditions. The results shown previously
ISSN: 2578-7160 |
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suggest that SAC transmission of ACh is indeed lost as
early as one week after the induction of glaucoma. In order to determine if restoring this transmission is neuroprotective to RGCs, pharmacological agents that act on
the synapse were administered as eye drop treatments.
DMP-543 enhances ACh release from pre-synaptic
cells [40,41]. If ACh is neuroprotective at the SAC-RGC
synapse, application of DMP-543 would be expected to
restore the neuroprotective effects of ACh on RGCs after inducing glaucoma. Indeed, quantification of RGC
survival upon treatment with different concentrations of
DMP-543 shows a dose-dependent neuroprotective effect on RGC numbers Figure 7. Figure 8 indicates that 10

Figure 6: Expression of α7 nAChRs in glaucoma-induced
retinas. This figure summarizes the expression of α7 nAChRs at multiple time points post-glaucoma-inducing procedure using a sandwich ELISA kit specific to the α7 nAChR.
*
indicates a significant decrease as compared to the untreated control condition. # indicates significance from 1 week.
Error bars report the standard error. P ≤ 0.05 represents significance. Ns of 6 are represented.

μM DMP-543 achieves a maximal neuroprotective effect
and prevented loss of RGCs associated with the procedure to induce glaucoma. ANOVA (F(6, 214) = 39.863,
p = 2.27E-32).
Donepezil, an acetylcholinesterase inhibitor, operates
within the same synapse to prevent the degradation of
ACh by the acetylcholinesterase enzyme. Similarly, with

Figure 8: Quantification of RGC survival with treatment of
DMP-543. This figure summarizes RGC count data at various time points before and after the procedure to induce
glaucoma. Rats were given daily eye drops with the indicated concentrations of DMP-543 for three days before glaucoma induction and for two weeks after. Cells were immunostained with an antibody against Thy 1.1. A minimum of
four high-resolution confocal z-stacks were taken per retina,
one from each quadrant 4 mm from the ONH. ImageJ analysis was then used to count Thy 1.1-positive RGCs within a
fixed sized grid. Cells were counted and averaged for each
retina (N = 1). The bar graph represents the average RGC
counts for each experimental condition. # indicates a significant change as compared to the untreated control condition.
*
indicates a significant change as compared to the glaucoma
condition. P ≤ 0.05 represents significance. Error bars represent standard error. Ns of 5 are represented.

Figure 7: Effects of DMP-543 treatment on RGC survival. This figure shows confocal images of a control untreated retina
(A), a glaucomatous retina four weeks after injection of hypertonic saline (B), and a glaucomatous retina treated daily with
10 μm DMP-543 eye drops for two weeks after injection of hypertonic saline (C). RGC bodies fluoresce in red (arrow) using
anti-Thy 1.1 antibody and axon fascicles are labeled with double arrows. These images are representative of the total number
of images collected for analysis. Scale bar represents 50 μm.
Cooley-Themm et al. J Ophthalmic Res Ocular Care 2017, 1(1):28-38

ISSN: 2578-7160 |

• Page 34 •

Citation: Cooley-Themm CA, Ameel Q, Linn DM, et al. (2017) Loss of Displaced Starburst Amacrine Cells in a
Rat Glaucoma Model. J Ophthalmic Res Ocular Care 1(1):28-38

Figure 9: Effects of Donepezil treatment on RGC survival. This figure shows a confocal control untreated retina (A), a glaucomatous retina four weeks after hypertonic injection (B), and a glaucomatous retina treated daily with 5 μm Donepezil eye
drops for two weeks after the procedure to induce glaucoma (C). RGC bodies are show in red using anti-Thy 1.1 antibody
(arrows). Axon fascicles are labeled with double arrows. These images are representative of the total number of images collected for analysis. The scale bar represents 50 μm.

83.419, p = 4.1E-32).

α7nAChR mRNA expression

Figure 10: Quantification of RGC survival with treatment of
Donepezil. This figure summarizes RGC count data at various time points post-injury. Rats were given daily eye drops
with the indicated concentrations of Donepezil for three days
before glaucoma induction and for two weeks after. Cells
were immunostained with an antibody against Thy 1.1. A
minimum of four high-resolution confocal z-stacks were taken per retina, one from each quadrant 4 mm from the ONH.
Image J analysis was then used to count Thy 1.1-positive
RGCs within a fixed sized grid. Cells were counted and averaged for each retina (N = 1). The bar graph represents
the average RGC counts for each experimental condition. #
indicates a significant change as compared to the untreated
control condition. *indicates a significant change as compared
to the glaucoma condition. P ≤ 0.05 represents significance.
Error bars represent standard error. Ns of 5 are represented.

the application of Donepezil, it is expected any remaining ACh would bind to ACh receptors longer and therefore, could rescue the neuroprotective effects of endogenous ACh. Quantification studies of RGC survival before and after Donepezil treatment also revealed a dose
dependent neuroprotective effect on RGC counts Figure
9. Figure 10 summarizes these effects. Specifically, 5 μm
Donepezil accomplished a maximal effect on RGC survival in hypertonic injected eyes. ANOVA (F(6, 79) =
Cooley-Themm et al. J Ophthalmic Res Ocular Care 2017, 1(1):28-38

To validate the finding that α7 nAChR receptor protein expression is lost prior to the RGC death, mRNASeq
analysis was conducted to observe expression of the receptor at the transcriptional level. This analysis also allowed us to investigate potential cell survival pathways
that might be down regulated in the glaucoma condition
compared to an untreated control condition. Fold change
data revealed a 1.23 fold decrease in expression of the α7
nAChR in glaucomatous retinas compared to untreated
control retinas (Figure 11) to support the hypothesis that
cholinergic transmission is lost in glaucoma conditions.
Previous in vitro studies from this lab have demonstrated that activation of α7nAChRs with a selective α7nAChR
agonist activates the PI3 Kinase-Akt-BCl2 cell survival
pathway in isolated RGCs [42]. When pathway analysis of
whole retinal mRNA transcripts was performed, a decrease
in mRNA expression was found in PI3 kinase, Akt and Bcl2
when eyes were injected with hypertonic saline to induce
glaucoma compared to control untreated conditions. Fold
changes of mRNA expression that occurred after inducing
glaucoma-like conditions are listed in Figure 11.

Discussion
The results from this study provide evidence of apoptotic loss of displaced SACs, corresponding with a reduction in ACh content and α7 nAChRs before any significant loss of RGCs occurs in an in vivo rat glaucoma
model. Is the loss of SACs and reduction of ACh a factor
in the eventual loss of RGCs associated with glaucoma?
If so, these results provide insight into the identification
of a possible new function for cholinergic amacrine cells
within the adult mammalian retina. Results from this study
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Figure 11: Proposed neuroprotective pathway (A) This figure shows a proposed neuroprotective pathway linking the activation of the α7 nAChR to a known cell survival pathway; (B) Reports mRNA Seq data corresponding to the proposed neuroprotective pathway. Specifically, fold change values for mRNA targets are listed.

demonstrate that cholinergic transmission is diminished
prior to significant RGC loss, and that application of
agents to affect ACh release and degradation at the amacrine cell-RGC synapse prevent RGC death. It is interesting to note that there was a significant loss of SACs after
the procedure to induce glaucoma within 1 week but the
remaining SACs remained for the duration of a month.
On the other hand, ACh content significantly decreased
in a time dependent manner between 1 and 4 weeks following the procedure to induce glaucoma-like conditions. This discrepancy between SAC numbers and ACh
release may be due to SACs that are damaged after the
procedure, which compromise the release of ACh over
time. Damage to SACs is supported by caspase-3 antibody studies. Results indicate many SACs are caspase-3
positive as early as 3 days following hypertonic injections.
Further investigation into the differential expression
of specific mRNA transcripts suggested down regulation of the PI3K-Akt-BCl2 cell survival pathway under
glaucoma-like conditions as well a down regulation of
transcripts for α7 nAChRs. This result supports previous in vitro ELISA studies performed on isolated adult
mammalian RGCs that demonstrated the PI3K-Akt-BCl2
pathway was involved in neuroprotection against glutamate-induced toxicity induced by the α7 nAChR selective agonist, PNU-282987 [42]. ACh has also been
implicated as a neuroprotective agent in neurodegenerative diseases. Alzheimer’s disease, for instance, is a neurodegenerative disorder characterized by neuronal loss
leading to brain atrophy. The activation of α7 nAChRs
has been studied as a potential neuroprotective approach
in Alzheimer’s disease models [43] and several studies
have linked neuroprotection induced by activation of α7
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nAChRs and the PI3K/Akt/Bcl-2 cell survival pathway
[44-46]. Activation of the α7 nAChR signaling cascade,
in particular, showed significant increase in cell viability, decreased number of apoptotic cells, decreased levels
of reactive oxygen species (ROS), and decreased levels
of caspase-3 in rat primary cortical neurons in a neurotoxic Alzheimer’s model. Blocking the receptor with
the antagonist, methyllycaconitine, MLA, eliminated the
neuroprotective effects [45]. It is therefore possible that
thePI3K/Akt/Bcl-2 cell survival pathway identified in an
in vitro RGC model of excitotoxicity is also involved in
ACh-induced neuroprotection of RGCs in adult mammals in glaucoma [16,18].
Additional pathways have also been implicated in
neuronal neuroprotection through the actions of the α7
nAChR. In an ischemic brain model, the activation of this
receptor acted through the nuclear factor erythroid-2 related factor (Nrf2) and its target gene, heme oxygenase
-1 (HO-1) to suppress cell death, ROS production, and
tumor necrosis factor (TNF) release [47]. However, the
model to induce glaucoma using hypertonic saline injections does not lead to ischemia and necrosis, but mimics
the increase of intraocular pressure typically associated
with glaucoma. As a result the procedures that induce
ischemia are not likely to trigger the same pathways as
the induced glaucoma model used in this study. Taken
together, the results presented here provide a collection
of evidence to support the hypothesis that ACh released
by displaced SACs in the RGC layer of adult mammalian
retina provides neuroprotection through the activation
of the α7 nAChR on RGCs. When that neuroprotection
is lost under glaucoma-like conditions, RGCs begin to
die. These results suggest a previously unidentified role
for displaced SACs and ACh in the adult mammalian
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retina.
Previous studies investigating starburst amacrine cell
survival using various glaucoma models have reported
inconclusive and even opposing results. One hereditary
model of glaucoma in mice showed that amacrine cell
populations were unaffected by the glaucoma condition
[35]. Another study, where experimental glaucoma was
induced using microbead injections demonstrated that
choline acetyltransferase (ChAT)-positive and glycinergic AC subtypes were unaffected [48]. However, an ischemic/reperfusion model of glaucoma reported a substantial reduction in transcripts for the SAC-specific enzyme,
choline acetyltransferase (ChAT) within 24 to 72 hours
[34]. Yet another lab showed that ChAT positive amacrine cell numbers decline within five weeks of episcleral
vein cauterization [36]. It is likely that conflicting results
associated with these studies are due to the different
methods and procedures used to induce glaucoma-like
conditions. In this study, we have used hypertonic injection of 2M NaCl saline to cause vascular scar tissue
and reduce outflow through the trabecular meshwork to
gradually increase intraocular pressure over time. This
reliable gradual increase of intraocular pressure is the
primary risk factor associated with glaucoma and was preferable over models that induced ischemia [34,49,50] or
that needed to inject microbeads multiple times to reduce drainage through the trabecular meshwork [48,51].
Results from this study lend support to the hypothesis
that SACs are lost in glaucoma. In addition, evidence was
provided that the SACs and neuroprotection provided
by ACh were lost prior to RGC loss.

Studies performed with DMP-543 and Donepezil
demonstrated that loss of RGCs could be prevented if
the reduction of ACh associated with the procedure
to induce glaucoma was supplemented with DMP-543
to enhance ACh release from remaining SACs or with
Donepezil to reduce the degradation of ACh on the
RGC postsynaptic membrane. These results provide
evidence of the neuroprotective action of ACh. When
ACh levels decrease under glaucomatous conditions,
cell survival pathways are no longer activated and loss
of RGC occurs. As a result, future glaucoma treatments
may involve a combination of treatments that target
intraocular pressure changes as well as regulation of
ACh levels in the retina.
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